For the Quarter Ending September 2025
APAC
• In China, the Albuterol Sulphate Price Index fell quarter-over-quarter in Q3 2025, driven by deflationary pressures.
• Albuterol Sulphate production costs decreased in September 2025, as the Producer Price Index fell 2.3% year-over-year.
• Petrochemical feedstock prices remained steady in Q3 2025, while Brent crude oil spot prices weakened.
• The Albuterol Sulphate demand outlook is bearish, influenced by a 0.3% CPI decline in September 2025.
• Consumer confidence at 89.6 and a 5.2% unemployment rate in September 2025 suggest reduced healthcare spending.
• China's general chemical demand slowed in 2025, impacting Albuterol Sulphate consumption and market sentiment.
• Industrial production increased 6.5% year-over-year in September 2025, ensuring stable raw material supply for production.
• Global overcapacity in the chemicals sector, particularly from China, persisted throughout Q3 2025, pressuring prices.
Why did the price of Albuterol Sulphate change in September 2025 in APAC?
• Deflationary pressures, with CPI falling 0.3% in September 2025, reduced overall market demand.
• Producer Price Index decreased 2.3% year-over-year in September 2025, lowering Albuterol Sulphate production costs.
• Contracting manufacturing activity in September 2025, alongside global overcapacity, pressured Albuterol Sulphate prices downwards.
Europe
• In Germany, the Albuterol Sulphate Price Index remained stable in Q3 2025, due to cautious demand and mixed cost pressures.
• Albuterol Sulphate production costs faced upward pressure from a 2.4% CPI increase in September 2025, impacting non-chemical inputs.
• Albuterol Sulphate manufacturing costs benefited from a 1.7% decrease in producer prices in September 2025, driven by lower energy costs.
• The Manufacturing Index was contracting in Q3 2025, indicating broader industrial slowdown and potential supply chain challenges.
• Albuterol Sulphate demand outlook remained cautious in Q3 2025, with customers exhibiting weak sentiment across chemical end markets.
• Industrial production declined 1.0% in September 2025, suggesting operational challenges affecting Albuterol Sulphate manufacturing.
• Germany's unemployment rate remained stable at 6.3% in September 2025, impacting healthcare affordability and Albuterol Sulphate access.
• Natural gas border prices in Germany fluctuated in Q3 2025, initially weakening then strengthening in September, affecting energy costs.
Why did the price of Albuterol Sulphate change in September 2025 in Europe?
• Albuterol Sulphate production costs increased due to 2.4% CPI rise in September 2025.
• Lower energy prices, a 1.7% PPI decrease in September 2025, reduced Albuterol Sulphate costs.
• Weak customer demand and contracting Manufacturing Index in Q3 2025 impacted Albuterol Sulphate prices.
North America
• In the United States, the Albuterol Sulphate Price Index rose quarter-over-quarter in Q3 2025, driven by increased production costs and robust demand.
• Albuterol Sulphate production costs increased due to a 2.6 percent rise in the Producer Price Index in August 2025 and higher natural gas prices.
• Demand for Albuterol Sulphate was supported by a 5.42 percent year-over-year increase in retail sales in September 2025, indicating strong consumer spending.
• The Albuterol Sulphate demand outlook is positive, bolstered by a low unemployment rate of 4.3 percent in September 2025, enhancing healthcare access.
• Chemical industry customer inventories for Albuterol Sulphate were assessed as low in Q3 2025, contributing to upward price pressure.
• Trade flows for imported goods into the U.S. faced tariff impacts and border delays in Q3 2025, affecting Albuterol Sulphate supply chains.
• The Albuterol Sulphate Price Forecast suggests continued upward pressure due to persistent input cost increases and strengthening pharmaceutical sector activity.
• Overall industrial production in September 2025 was only 0.1 percent above its year-earlier level, suggesting broader economic headwinds.
• Consumer confidence declined to 94.2 in September 2025, potentially leading to increased price sensitivity for essential medications like Albuterol Sulphate.
Why did the price of Albuterol Sulphate change in September 2025 in North America?
• Rising input costs, evidenced by a 2.6 percent PPI increase in August 2025, directly elevated Albuterol Sulphate production expenses.
• Strong consumer spending, with retail sales up 5.42 percent in September 2025, supported consistent demand for essential pharmaceuticals.
• Low customer inventories in Q3 2025, coupled with higher U.S. natural gas prices, contributed to the upward price trend.
